INTRODUCTION
The prevalence of preterm birth is widespread with very little understanding of its causes and no unambiguous epidemiological data for predicting its occurrence. Formed in weeks 30 to 33 of pregnancy (Wilson and Maibach, 1980) , the protective epidermal permeability barrier (EPB) of the skin is essential for survival as it provides the first line of defense against infection, environmental insult, and the loss of heat and solutes (Baharestani, 2007; Gibson et al., 2006; Shwayder and Akland, 2005; Soll, 2008) . In infants born before 32 weeks of pregnancy, severe EPB dysfunction may result in death or long-term complications (Pilling et al., 2008) .
The EPB is formed in the later stages of epidermal terminal differentiation, and consists of tight junction (TJ) strands of adjacent cells that associate laterally (Brandner, 2009; Brandner et al., 2002; Langbein et al., 2002; Langbein et al., 2003; Schluter et al., 2007; Turksen and Troy, 2002) and function in sealing intracellular spaces for paracellular diffusion control (Farquhar and Palade, 1963) . The selective permeability of the EPB is provided by a family of 23 highly conserved integral membrane proteins known as claudins (Cldns), a relatively recently identified component of TJs (Angelow et al., 2008; Chiba et al., 2008; Findley and Koval, 2009; Krause et al., 2008; Turksen and Troy, 2004; Van Itallie and Anderson, 2006) . Heterogeneity within the Cldn family results from distinctly charged amino acid sequences within the first external loop; thus, the specific permeability properties of different epithelia are attributed to their different Cldn compositions (Daugherty et al., 2007; Katoh, 2003; Krause et al., 2008; Turksen and Troy, 2004) . Recent studies have clearly demonstrated that Cldn-containing TJs are intricately involved in epidermal differentiation programs, and that TJ function, and thus barrier integrity, is modified in response to Cldn modulation (Arabzadeh et al., 2006; Furuse et al., 2002; Troy et al., 2005b; Turksen and Troy, 2002) . For instance, Cldn1 knockout mice die shortly after birth owing to EPB dysfunction . Inv-Cldn6 transgenic mice, in which the involucrin (Inv) promoter targets Cldn6 to the suprabasal layers of the epidermis, also suffer EPB abnormalities with a phenotype mimicking that seen in premature human babies, the severity/lethality of which is dependent upon the level of Cldn6 overexpression (Troy et al., 2005b; Turksen and Troy, 2002) . Inefficient membrane targeting of Cldn proteins and a highly proliferative epidermal phenotype -apparently as a result of the unfolded protein response pathway -were observed upon overexpression of a cytoplasmic tail-ablated Cldn6 (Inv-Cldn6-C187) in mice (Arabzadeh et al., 2006) . Furthermore, dependent on the level of overexpression, Inv-Cldn6-C196 mice (with half the cytoplasmic tail ablated) 
SUMMARY
Preterm birth is a major global health problem that results in a large number of infant deaths, many of which are attributable to the complications of an immature epidermal permeability barrier (EPB), for which there is currently no effective therapeutic option. The mammalian EPB is formed during development and is essential for survival as it maintains thermoregulation and hydration, and provides a defense against infection. Using transgenic mouse technology, we have demonstrated the importance of claudin (Cldn)-containing tight junctions (TJs) in epidermal differentiation and, in particular, that epidermal suprabasal overexpression of Cldn6 results in an EPB-deficient phenotype that phenocopies the dysfunctional EPB of premature human infants. In this study, we used the same approach to target a Cldn6 tail deletion mutant to the epidermis of mice [involucrin (Inv)-Cldn6-C206 transgenic mice]. The Inv-Cldn6-C206 transgenic mice displayed a developmental delay in EPB formation, as shown by the expression of keratins and Cldns, and by X-Gal penetration assays. Trans-epidermal water loss measurements and immunolocalization studies indicated that the epidermal differentiation program was also perturbed in postnatal Inv-Cldn6-C206 transgenic mice resulting in a delayed maturation. Notably, however, expression/localization of epidermal differentiation and maturation markers, including Cldns, indicated that the transgenic epidermis matured and normalized by postnatal day 10, which is 3 days after the wild-type epidermis. Our results suggest that activation of the extracellular signal-regulated kinase 1/2 (Erk1/2) pathway and Cldn1 phosphorylation are associated with the repair and maturation of the skin barrier processes. These studies provide additional support for the crucial role of Cldns in epidermal differentiation, maturation and the formation of the EPB, and describe a novel animal model for evaluating postnatal epidermal maturation and therapies that may accelerate the process.
dysfunction and an aging-related skin barrier defect resulting in an intrinsic propensity for injury, inefficient repair and chronic dermatitis.
These data provide support for the importance of the cytoplasmic tail portion of Cldn molecules in epidermal differentiation and EPB function. Although relatively constant in length, sequences within the Cldn cytoplasmic tail are divergent but include a number of putative functional domains that are present in many family members. To continue to address functional domain activities, we again used the Inv promoter to target a Cldn6 cytoplasmic tail deletion mutant (Cldn6-C206), to the suprabasal compartment of the epidermis; this deletion encompasses the PDZ-binding domain and a putative protein kinase A (PKA) phosphorylation site. Inv-Cldn6-C206 transgenic mice have a developmental delay in EPB formation, suffer trans-epidermal water loss (TEWL) at birth, and exhibit a perturbed epidermal maturation program manifested by a 3-day lag in the initiation of the normal epidermal thinning process (which occurs at day 10 in the Inv-Cldn6-C206 transgenic mice versus day 7 in the wild-type epidermis). Our data suggest that this process stems from the remodeling of Cldn1 expression in the repairing Inv-Cldn6-C206 transgenic epidermis, and that the first phase of repair requires shedding of phospoCldn1-expressing cells from the differentiated epidermal compartment where extracellular signal-regulated kinase 1/2 (Erk1/2) is activated. These results suggest that although Inv-Cldn6-C206 transgenic mice suffer developmental delays in epidermogenesis, the epidermis undergoes epidermal maturation and repair after birth, normalizing by postnatal day 10, thus providing a model to elucidate the molecular mechanisms by which Cldns regulate the postnatal maturation of the epidermis. This model may also be useful to screen for agents that accelerate formation of a functional barrier, which could provide useful therapeutic options for improvement of the EPB in premature infants.
RESULTS

Generation and phenotype of Inv-Cldn6-C206 transgenic mice
We truncated the C-terminal cytoplasmic tail domain of Cldn6 after amino acid 206 (Cldn6-C206), removing 14 amino acids to encompass a region including the PDZ-binding domain (YV) and a putative PKA phosphorylation site (Fig. 1A,B) . Cldn6-C206
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Delayed epidermal permeability barrier formation and repair RESEARCH ARTICLE Fig. 1 . Inv-Cldn6-C206 transgenic mice. (A)The Inv-Cldn6-C206 mutant was created by truncating the C-terminal cytoplasmic tail domain of Cldn6 after amino acid 206 (Cldn6-C206). (B)The Cldn6 protein sequence is shown; transmembrane-spanning regions are encased within boxes, the CXXC motifs are underlined, and the deletion site is indicated with an arrow. (C)Cldn6-C206 cDNA was expressed in the suprabasal cells of the transgenic mouse epidermis, where TJs are localized, under the control of the 3.7 kb 5Ј-flanking element of the human involucrin gene. (D)Inv-Cldn6-C206 mice were easily identifiable by their wiry and lackluster coat, a phenotype that was maintained throughout life. (E)TEWL measurements demonstrated an approximately twofold increase in water loss for transgenic neonates, and daily measurements revealed a robust epidermal repair mechanism where normal hydration levels were achieved by 4 days after birth. (F)RT-PCR using primers spanning the Inv exon and Cldn6 confirmed that transgene expression was consistent and could therefore not be used to explain the changes in TEWL; GAPDH controls are shown. (G,H)Evaluation of cornified envelopes, which were characterized by a rigid shape and uniform size, comparable to that of the wild type (G), and the absence of X-Gal penetration (H) confirmed the presence of sufficient neonatal barrier function in Inv-Cldn6-C206 mice.
cDNA was expressed in the suprabasal cells of the transgenic mouse epidermis, where TJs are localized, under the control of the 3.7 kb 5Ј-flanking element of the human Inv gene (IVL) (Fig. 1C) . Founder Inv-Cldn6-C206 transgenic mice (five females) were identified by PCR, and two lines were established with identical phenotypes. Newborn Inv-Cldn6-C206 transgenic mice appeared grossly phenotypically comparable to the wild type. However, as was observed in our Inv-Cldn6, Inv-Cldn6-C187 and Inv-Cldn6-C196 mouse models, with time the Inv-Cldn6-C206 transgenic mice were easily distinguishable from the wild type by coat appearance: smooth and shiny in the wild-type mice versus wiry and lackluster in the transgenic mice, a phenotype that was maintained throughout the life of the mouse (Fig. 1D) . Since it does not appear to have any direct relevance to the delayed epidermal maturation and postnatal EPB formation reported here, coat characteristics have not been investigated further.
Although no gross phenotypic abnormalities were apparent at birth, daily dermal phase meter (DPM) measurements (Fig. 1E ) demonstrated significant, albeit non-lethal, TEWL in neonatal InvCldn6-C206 transgenic mice. Compared with the wild-type mice (DPM in the range of 95-105), Inv-Cldn6-C206 transgenic neonates expressed DPM values in the range of 175-185. However, DPM levels were already reduced in the transgenic mice at 2 days after birth (~125-135), and by 4 days after birth, DPM values reached wild-type levels (in the range of 100-106). Reverse transcriptase (RT)-PCR with primers spanning the junction of the Inv exon and the Cldn6 sequences in the transgene confirmed that the observed changes in TEWL leading to reversion to a normal or wild-type phenotype are not simply the result of decreased expression of the transgene (Fig. 1F , a GAPDH control is shown). Despite the higher TEWL in transgenic epidermis, the presence of substantial neonatal barrier function was confirmed not only by mouse viability but also by analysis of cornified envelope extracts from Inv-Cldn6-C206 skin, which appeared relatively normal with a uniform size and rigid shape (Fig. 1G) , and the absence of X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside) penetration (Fig. 1H) .
Barrier formation and epidermal differentiation is delayed in the Inv-Cldn6-C206 transgenic epidermis during development Although non-lethal, the significantly higher TEWL observed in neonatal Inv-Cldn6-C206 transgenic mice suggested aberrations in the epidermal differentiation program during development. XGal penetration assays confirmed that, at E15.5 (15.5 days post coitum), Inv-Cldn6-C206 transgenic embryos were delayed in barrier formation as compared with their wild-type counterparts ( Fig. 2A) , a delay that was sustained at E17.5, when EPB function is normally achieved (Fig. 2B) (Hardman et al., 1998; , and at E18.5 (Fig. 2C , marked with arrows).
To complement these studies, we evaluated transverse histological sections of E15.5 and E17.5 embryo torsos in which the epidermal initiation sites, as well as the dorsal and ventral midlines, were included; because the data were consistent, we report results from E15.5 Inv-Cldn6-C206 transgenic and wildtype mice only. At each site, a somewhat delayed/immature epidermal differentiation program was evident in the transgenic epidermis. For instance, in contrast to the well-established 3-4-cell layered stratum intermedium of the wild-type epidermis (Fig.   3A) , the initiation site of the Inv-Cldn6-C206 transgenic epidermis possessed only 2-3 intermediate cell layers. Although the dorsal midline (Fig. 3B) Consistent with the histological results, abnormalities in the expression of epidermal differentiation markers and Cldns were present in the developing Inv-Cldn6-C206 embryo (Fig. 4, E15 .5 epidermal initiation sites are shown). Although there was no apparent difference in the transgenic and wild-type epidermal basal compartments, as shown by the localization of K14 (Fig. 4A ), K5 and K15 (not shown), K1 (Fig. 4B) , which is associated with
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Fig. 2. X-Gal assays demonstrate a developmental delay in EPB formation
for Inv-Cldn6-C206 transgenic mice. (A-C)Using age-matched wild-type embryos as a control, X-Gal penetration assays at E15.5 (A), E17.5 (B) and E18.5 (C) confirmed a developmental delay in EPB formation for Inv-Cldn6-C206 transgenic mice. Even at E18.5 there was some evidence that barrier formation
had not yet been completed in Inv-Cldn6-C206 transgenic embryos (indicated with arrows).
stratifying suprabasal cells (Fuchs and Byrne, 1994) , occupied a moderately thinner compartment in the transgenic epidermis corresponding with the thinner intermediate layer that was observed histologically. Cldn1 (
) and Cldn18 ( Fig. 4G ), which at this developmental time point are all strictly localized to the epidermal suprabasal compartment , also occupied a comparatively thinner zone of expression in the developing InvCldn6-C206 transgenic epidermis. Similarly, the expression compartment of various structural proteins in the stratum corneum, including involucrin ( 
The epidermis matures postnatally in the Inv-Cldn6-C206 transgenic mice
In parallel with the delayed program of epidermal differentiation and EPB formation observed in the developing Inv-Cldn6-C206 transgenic epidermis, postnatal TEWL measurements suggested that the Inv-Cldn6-C206 transgenic epidermis underwent a robust epidermal maturation process after birth. Histological analyses of newborn ( Fig. 5A ), 2-day-old and 4-day-old skin samples (not shown) revealed that the Inv-Cldn6-C206 transgenic epidermis was comparable to the wild type. However, although by 1 week of age the wild-type epidermis had commenced the normal thinning pattern associated with epidermal maturation, the transgenic epidermis maintained an immature phenotype with many suprabasal cell layers, the prevalent appearance of nuclei in the upper differentiation layers, and a much less compacted granular layer (Fig. 5B) . However, by 10 days after birth (Fig. 5C ), the Inv-Cldn6-C206 transgenic epidermis had thinned to be morphologically comparable to the wild-type epidermis. Samples from 1-month-old ( Fig. 5D ) and 3-month-old (not shown) transgenic mice were indistinguishable from wild-type samples.
The histological results suggested that changes occurred in the transgenic epidermis reflecting approximately a 3-day lag in the normal epidermal maturation process, a possibility supported by the expression of epidermal differentiation markers and Cldns. Because results were similar from newborn to 7 days of age, normalized after 10 days, and were maintained throughout life, we report results only from 7-and 10-day-old Inv-Cldn6-C206 transgenic mice compared with 7-day-old wild-type mice. K5 and K15 were restricted to basal cells at all time points in both the wildtype and Inv-Cldn6-C206 epidermis (not shown), but K14 occupied an expanded zone extending into the suprabasal compartment until epidermal maturation was achieved in the 10-day-old Inv-Cldn6-C206 transgenic epidermis (Fig. 6A ). K6 and K17, which are keratins associated with a hyperproliferative epidermis (Leigh et al., 1995; McGowan and Coulombe, 1998a; McGowan and Coulombe, 1998b) , were not expressed throughout the time analyzed (not shown); however, a broadened K1 (Fig. 6B ) expression compartment was seen in the transgenic epidermis early after birth, but normalized by 10 days of age. Similarly, the expression compartments for involucrin ( Fig. 6C) , filaggrin (Fig .  6D ) and loricrin ( Fig. 6E ) were also expanded, with an obvious packing defect reminiscent of the observed histological abnormalities of the stratum corneum, in the immature Inv-Cldn6-C206 transgenic epidermis until thinning that was comparable to the wild-type epidermis was achieved.
In parallel with changes in epidermal markers, the suprabasalspecific Cldns, Cldn6 ( Each of these Cldns was normalized, with a strictly membranous localization, upon epidermal maturation to a phenotype that was comparable to the wild type. Cldns not normally expressed in the epidermis (e.g. Cldn2, Cldn3 and Cldn5) (Turksen and Troy, 2002) were not observed in either the wild-type or Inv-Cldn6-C206 transgenic epidermis at any time evaluated (not shown).
We also compared the expression of markers previously reported to be modulated during the epidermal maturation process in the newborn, 4-, 7-and 10-day-old transgenic mice compared with the wild-type epidermis. Changes in the overall surface pH of the epidermis contribute to the activation of enzymes involved in lipid processing for EPB function, and the plasma membrane Na + /H + exchanger 1 (NHE1) has been implicated in this process (Behne et al., 2003; Fluhr et al., 2004a; Fluhr et al., 2004b; Hachem et al., 2005) .
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Delayed epidermal permeability barrier formation and repair RESEARCH ARTICLE Consistent with earlier reports (Behne et al., 2003) , we found that NHE1 was localized in a 'punctate' pattern at the cell membrane of the basal and suprabasal compartments of the newborn wildtype epidermis, and as epidermal maturation progressed, NHE1 was gradually downregulated with localization restricted to the basal compartment by 7 days after birth (Fig. 8A-D, right column) . By contrast, NHE1 was persistently upregulated and associated with both the basal and suprabasal cell compartments of the Inv-Cldn6-C206 transgenic epidermis from birth to 7 days of age; downregulation and strict basal cell association was not observed until postnatal day 10 ( Fig. 8A-D , left column). Immunoblot ( Fig.  8E ) and RT-PCR (Fig. 8F ) analyses supported these findings. Similarly, aquaporins (AQPs), which are small integral membrane proteins that selectively transport water across cell membranes, and key lipid processing enzymes [-glucocerebrosidase (-celerase) and acid sphingomyelinase (SMase)] that are important in EPB homeostasis (Behne et al., 2003; Hara-Chikuma and Verkman, 2008) were also modulated in the Inv-Cldn6-C206 transgenic epidermis versus the wild-type epidermis, as shown by immunoblot (Fig. 8E ) and RT-PCR (Fig. 8F) analyses.
Changes in Cldn1, phosphoCldn1 and Erk1/2 expression profiles delineate repair and maturation processes in the Inv-Cldn6-C206 transgenic epidermis The relatively rapid postnatal normalization of TEWL in Inv-Cldn6-C206 transgenic mice, together with the morphological and marker expression changes observed, suggested a robust maturational or repair process. Previous studies, including our own (see above), have demonstrated the importance of Cldn1 in epidermal morphogenesis, differentiation, and EPB formation and
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Delayed epidermal permeability barrier formation and repair repair. In particular, the expression of Cldn1 is unique compared with other Cldns and undergoes a maturation switch, from a strictly suprabasal association to being localized to cell-cell borders in all the living layers of the epidermis, coinciding with the acquisition of barrier function during epidermogenesis . This normal expression profile is maintained throughout life except in response to acute injury and in tumorigenesis, where basal layer association is lost, and Cldn1-null epithelial cells are progressively more frequent in the lower suprabasal compartment (Arabzadeh et al., 2007; Arabzadeh et al., 2008) . In comparison to the wild-type
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Delayed epidermal permeability barrier formation and repair RESEARCH ARTICLE Fig. 5 . Histological abnormalities in the Inv-Cldn6-C206 transgenic epidermis after birth. (A)Histological analyses of skin samples revealed that, at newborn stages, the Inv-Cldn6-C206 epidermis was comparable to the wild type. (B)However, it was evident that, after 7 days, the transgenic epidermis did not undergo the normal process of maturation/thinning that was observed in the wild-type epidermis and was characterized by an increased number of suprabasal cell layers, the prevalent appearance of nuclei in the upper differentiation layers, and a much less compacted granular layer. However, representing a 3-day lag behind the wild type, the transgenic epidermis thinned to be morphologically comparable to the wild type by 10 days after birth (C), a phenotype that was maintained after 1 month (D) and throughout life. Bar, 20m. Changes in the epidermal differentiation program of the InvCldn6-C206 transgenic epidermis were evaluated by immunofluorescence and compared with their age-matched wild-type counterparts (samples from 7 and 10-day-old transgenic mice are shown and compared with the mature wild-type epidermis at 7 days). (A)In the transgenic epidermis, K14 occupied an expanded zone extending into the suprabasal compartment until epidermal maturation was achieved. (B)K1 was first observed in an expanded zone of expression, but normalized by 10 days of age in the Inv-Cldn6-C206 transgenic epidermis. (C-E)Similarly, broadened expression compartments and obvious packing defects for involucrin (C), filaggrin (D) and loricrin (E) characterized the immature Inv-Cldn6-C206 transgenic epidermis until thinning comparable to the wild type was achieved. Bar, 20m. basal to suprabasal localization of Cldn1 (Fig. 9A-D, right column) , Cldn1-null epidermal cells were observed in the basal and lower suprabasal layers of the Inv-Cldn6-C206 transgenic epidermis from 4-7 days after birth; as anticipated based on normalization of TEWL and morphology, Cldn1 localization was normalized in samples from 10-day-old mice ( Fig. 9A-D, left column) . Although no differences were detected in mRNA levels (Fig. 9F) , immunoblotting confirmed decreased Cldn1 protein levels (Fig. 9E ) in samples of 2-day-old Inv-Cldn6-C206 transgenic epidermis. Given the evidence suggesting that the phosphorylation of different Cldns is involved in either the strengthening or weakening of TJs, and in parallel barrier function (D'Souza et al., 2007; Findley and Koval, 2009; Ikari et al., 2008) , we next asked whether expression of the phosphorylated form of Cldn1 (phosphoCldn1) was altered in transgenic versus wild-type epidermis. PhosphoCldn1 was not observed in the wild-type epidermis at any of the time points assayed (data not shown). However, phosphoCldn1 was localized to cell-cell borders in the upper suprabasal zone of the newborn Inv-Cldn6-C206 transgenic epidermis until epidermal repair was achieved at postnatal day 10 ( Fig. 10A-D) . Concomitantly, expression of Erk1/2 followed the same distribution pattern of phosphoCldn1 (Fig. 10E-H) with a considerable amount of Erk1/2 localized to the cell membrane of differentiating cells in the newborn, 4-, 7-and 10-day-old Inv-Cldn6-C206 transgenic epidermis.
DISCUSSION
In this study, we describe the generation of a novel animal model for evaluating developmental delays in EPB formation and the postnatal epidermal maturation processes that are analogous to those observed in the dysfunctional barrier phenotype of human premature babies. Using skin penetration assays and immunohistochemistry to evaluate the expression and localization of classical markers of epidermal differentiation and maturation, as well as the Cldns and signaling molecules that are involved in EPB formation, we demonstrated that Inv-Cldn6-C206 transgenic mice suffered a developmental delay in epidermal differentiation and EPB formation leading to significant TEWL at birth, despite sufficient neonatal barrier formation (the presence of a cornified envelope) and function (the absence of X-Gal penetration) for survival. Postnatal TEWL measurements, along with changes observed in the expression and localization of keratins and Cldns, suggested that the Inv-Cldn6-C206 transgenic epidermis underwent a robust epidermal maturation process after birth to become indistinguishable from the wild type. Although the molecular mechanisms underlying the delayed maturation and repair of the epidermis and EPB in these transgenic mice have not yet been delineated, our data indicate that the Inv-Cldn6-C206 mice constitute an attractive model from a therapeutics point of view, i.e. for the identification of lead compounds for accelerated repair of the often life-threatening permeability barrier defects in premature human infants.
Many studies have described the developmental formation of the EPB (Byrne and Hardman, 2005; Hardman et al., 1999; Hardman et al., 1998; Turksen and Troy, 2002) and it is well recognized that a disruption or delay in its formation before birth may have severe consequences to the survival of the organism (Cartlidge, 2000; Elias, 2005; Mack et al., 2005; Williams et al., 1998) . We described previously that perturbations of Cldn6 expression levels in the suprabasal compartment of the epidermis -its endogenous siteresult in epidermal differentiation abnormalities and EPB dysfunction (Troy et al., 2005b; Turksen and Troy, 2002) . However, depending on the level of expression, and whether normal or mutant forms of Cldn6 are expressed, the severity of the phenotype varies (Arabzadeh et al., 2006; Troy et al., 2005b; Turksen and Troy, 2002) . For example, severe EPB dysfunction manifested in extreme TEWL and neonatal lethality occurs when native Cldn6 is expressed at high levels (Turksen and Troy, 2002) , whereas lower levels of expression result in less severe EPB dysfunction and postnatal normalization (Troy et al., 2005b) . Overexpression of a mutant form of Cldn6 lacking its entire tail domain (Inv-Cldn6-C187 mice) does not appear to manifest in any prenatal epidermal developmental defects, but an abnormal,
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Delayed epidermal permeability barrier formation and repair RESEARCH ARTICLE Fig. 7 . Evaluation of Cldns in the delayed EPB of Inv-Cldn6-C206 transgenic mice. The expression/localization of Cldns was also perturbed in the immature Inv-Cldn6-C206 epidermis (7-and 10-day-old transgenic samples are shown and compared with the mature wild type samples at 7 days). (A-D)Cldn6 (A), Cldn11 (B), Cldn12 (C) and Cldn18 (D) were observed in an expanded zone early on, demonstrating a loss in membranous localization, and were normalized by 10 days after birth. Bar, 20m.
postnatal, lifelong epidermal hyperproliferation is observed (Arabzadeh et al., 2006) . High overexpression of a different mutant lacking only the C-terminal half of the tail domain of Cldn6 (InvCldn6-C196 mice) results in a lethal barrier dysfunction with marked hyperproliferative squamous invaginations/cysts replacing hair follicles, while lower-level expression manifests in an aging-related skin barrier defect resulting in an intrinsic propensity for injury, inefficient repair and chronic dermatitis. We now show that transgenic mice expressing a mutant Cldn6 with a shorter tail deletion (removing the PDZ domain and a putative PKA phosphorylation site) possess a distinct developmental defect in epidermal differentiation resulting in EPB formation delays and that a robust repair response occurs for postnatal epidermal maturation. It is notable that formation of a skin barrier with functional TEWL characteristics that are indistinguishable from the wild type occurred more rapidly than, or prior to, complete morphological maturation of the epidermis in the postnatal Cldn6-C206 mice, indicating an ability to disconnect aspects of the two processes, an observation that is interesting from a developmental standpoint but that may also be therapeutically important (see below). The mechanisms by which the expression of Cldn6-C206 results in a developmental delay in EPB formation and postnatal epidermal maturation and repair are not yet known, but our observations support the need for Cldn homeostasis in a bona fide epidermal differentiation program and in epidermal repair. We have previously demonstrated that there is a defined Cldn expression profile in the epidermis and that changes in epidermal differentiation elicit concomitant modifications in the Cldn expression profile and vice versa (Troy et al., 2005b; Turksen and Troy, 2002; Turksen and Troy, 2004) . Upon injury, or in response to differentiation abnormalities, the spatial expression of the suprabasal Cldns (Cldn6, Cldn11, Cldn12 and Cldn18) generally expands or shrinks to encompass all the cells of the perturbed suprabasal zone, with some concomitant loss in cell membrane association (Arabzadeh et al., 2006; Arabzadeh et al., 2007; Arabzadeh et al., 2008; Troy et al., 2005b; Turksen and Troy, 2002) . This was also true in the immature Inv-Cldn6-C206 epidermis: as the epidermis matured, by postnatal day 10, the localization and expression of the Cldns normalized to a strictly membranous association in a suprabasal zone that was comparable in thickness to that of the wild type. However, Cldn1 undergoes more dramatic alterations in response to epidermal homeostasis dysregulation. In the developing epidermis, Cldn1 is first restricted to the stratifying layers and matures to occupy the basal layer upon the completion of barrier formation at E17.5 . However, in response to TPA (12-O-tetradecanoyl-phorbol-13-acetate)-
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Delayed epidermal permeability barrier formation and repair RESEARCH ARTICLE Fig. 8 . Modulation in NHE1 expression/localization. (A-D)Localization of NHE1 was evaluated in skin samples from newborn (A), 4-day-old (B), 7-dayold (C) and 10-day-old (D) Inv-Cldn6-C206 transgenic mice (left column) compared with wild-type mice (right column). In the Inv-Cldn6-C206 transgenic epidermis, NHE1 was upregulated and associated with both the basal and suprabasal cell compartments from newborn to 7 days after birth; downregulation and strict basal cell association was not observed until postnatal day 10. Bar, 20m. These data were supported by immunoblot (E) and RT-PCR (F) analyses. Modulations in mRNA or protein levels of AQP1, -celerase and SMase are also shown relative to GAPDH controls.
induced injury and the loss of cell polarity that is seen in tumorigenesis, Cldn1 expression is downregulated in both the basal layer and immediate suprabasal layers of the epidermis (Arabzadeh et al., 2007; Arabzadeh et al., 2008) . These changes are also observed in the intrinsic aging process of the Inv-Cldn6-C196 transgenic epidermis and in the delayed epidermal maturation that we now report in Inv-Cldn6-C206 transgenic mice. Notably, Cldn1 expression normalized with the normalization of epidermal differentiation markers and epidermal maturation (see below).
Although Cldns demonstrate amino acid similarity among family members, the cytoplasmic tails of Cldns are divergent in sequence and possess a number of sites that provide clues about their structure-function relationships in epidermal differentiation, including a PDZ binding sequence (YV) and potential phosphorylation sites (Fujibe et al., 2004; Simard et al., 2006) .
Disease Models & Mechanisms 175
Delayed epidermal permeability barrier formation and repair RESEARCH ARTICLE Fig. 9 . Changes in Cldn1 expression and localization in the Inv-Cldn6-C206 transgenic epidermis. Unlike the normal wild type (right column) basal to suprabasal localization of Cldn1, the Inv-Cldn6-C206 transgenic epidermis (left column) showed abnormalities. (A-C)Although localization was normal at newborn stages (A), Cldn1-null epidermal cells were observed in the basal and lower suprabasal layers from 4 days (B) to 7 days (C) after birth, and were normalized by 10 days after birth (D). Bar, 20m. (E-F)Immunoblotting confirmed the changes in Cldn1 protein level (E); whereas RT-PCR indicated that there were no differences at the mRNA level (F). Proteins with a PDZ domain such as the membrane-associated guanylate kinase (MAGUK) family proteins [zonula occludens (ZO)-1, ZO-2 and ZO-3] (Itoh et al., 1999) , as well as the recently identified multi-PDZ domain scaffolding proteins PATJ (protein associated to tight junctions) (Lemmers et al., 2002) and multi-PDZ domain protein 1 (MUPP-1) (Hamazaki et al., 2002) , selectively recognize and bind to this sequence (for a review see GonzalezMariscal et al., 2003) . However, it seems likely that as yet unidentified novel molecules interact with Cldns in regulating gene expression and epidermal differentiation. Post-translational modifications within the tail domain, including phosphorylation and palmitoylation, are also thought to regulate Cldn activities, including their targeting to the membrane and their insertion into TJs to regulate paracellular permeability (Simard et al., 2006) . Phosphorylation of a number of Cldns has been demonstrated to be required for their assembly into TJs [e.g. for Cldn1 and Cldn4 (Banan et al., 2005) , and for Cldn16 (Ikari et al., 2008) ] but, to date, most Cldns have not been subjected to exhaustive analysis. Our observation of the association of phosphoCldn1 with the differentiated layers of the immature Inv-Cldn6-C206 transgenic epidermis points towards the potential role of Cldn1 phosphorylation in the process of epidermal maturation and EPB repair.
Although the precise sequence of events in the maturation of the skin barrier is not well understood, the notion that exposure to air after birth functions to initiate and accelerate the maturation and repair of the skin barrier has been suggested (Hanley et al., 1997; Williams et al., 1998) . The fetal and neonatal anomalies with spontaneous and apparently complete epidermal maturation and barrier repair that we observe in postnatal Inv-Cldn6-C206 transgenic mice support the view that exposure to air induces an intrinsic repair and maturation pathway. Other support for this hypothesis comes from a number of studies; for example, exposing embryonic immature epidermis to air (Williams et al., 1998) , lifting skin-equivalent cultures to the air-liquid interface (Fartasch and Ponec, 1994; Komuves et al., 1999) , and inducing injury to the EPB by tape stripping (Ahn et al., 1999; Ahn et al., 2001 ) each result in a robust EPB repair and epidermal maturation response. Although collectively these studies do not provide a mechanism for the observed intrinsic repair/maturation process in the epidermis, our studies suggest that the first phase of repair is the shedding of defective differentiation layers, which we identified as phospoCldn1-expressing cells with co-expression of high levels of Erk1/2. Considering the important role of Erk1/2 in epithelial differentiation (Hobbs et al., 2004; Taupin and Podolsky, 1999; Yu et al., 2007) , as well as in the regulation of Cldn expression (Lipschutz et al., 2005) , our data support a role for Erk1/2 in the initiation or progression of the epidermal repair and maturation that was observed in Inv-Cldn6-C206 transgenic mice. Concomitantly, initiation probably also involves the well-known phenomena of cross-talk between the differentiating and the basal compartments of the epidermis, which has been demonstrated to tightly regulate the epidermal differentiation program and is responsible for the normal maintenance program of the epidermis (Prowse et al., 1999; Troy et al., 2005b) ; evidence for this comes from our reported observations regarding the remodeling of Cldn1 expression in the repairing Inv-Cldn6-C206 transgenic epidermis. Further analyses are required to understand how 'air exposure' activates the Erk1/2 pathway and the observed Cldn1 phosphorylation process.
Although a variety of maternal and fetal diseases and conditions can lead to premature birth, the reasons underlying the quite dramatic increases in premature birth, in not only underdeveloped but also developed countries, over the last decade are unknown (Darmstadt et al., 2008; Lang and Iams, 2009; Yeaney et al., 2009) . Complications owing to comprised skin barrier function (e.g. poor temperature regulation and dehydration) in premature babies are among the primary causes of neonatal sepsis and mortality (Rutter, 1996; Rutter, 2000; Saiman, 2006) . Given the importance of skin barrier function in the health of premature babies and the fact that intrinsic risk factors of sepsis include compromised portals of entry for pathogens (Saiman, 2006) , there is a surprisingly significant lack of successful approaches/strategies that have been designed specifically to accelerate the postnatal maturation of the epidermis (McIntire and Leveno, 2008; ShapiroMendoza et al., 2008; Shapiro-Mendoza et al., 2006; Tyson et al., 2008) . Strategies for reducing the rate of sepsis are currently focused on limiting the spread of infection through aseptic clinical techniques and the use of antibiotics, which are increasingly becoming ineffective (Saiman, 2006) . In addition, the topical application of relatively low-cost emollients, especially in underdeveloped countries, has proven to have some benefit, although whether this is from provision of a mechanical barrier or from induction of biological responses to some of the ingredients, or both, is not clear (Darmstadt et al., 2008) . Understanding these mechanisms, as well as screening for potential novel therapeutics to accelerate postnatal epidermal maturation, have been hampered by the lack of suitable in vivo models. The capacity of the Inv-Cldn6-C206 transgenic epidermis to undergo a postnatal repair response and acquire a mature epidermis by 10 days after birth makes this transgenic model an excellent tool for investigating not only the molecular changes taking place during this maturation period, but also for screening for novel therapeutics to accelerate this process and improve the health of human premature infants.
METHODS
Generation of Inv-Cldn6-C206 transgenic mice
Inv-Cldn6-C206 mice were generated by truncating the cytoplasmic tail domain of Cldn6 after amino acid 206 (Cldn6-C206) and then subcloning Cldn6-C206 into the NotI site of the Inv cassette (H3700-pL2) by our previously utilized strategy (Arabzadeh et al., 2006; Turksen and Troy, 2002) . Purified DNA was injected into ova collected from superovulated CD1 mice at the Transgenic Mouse Facility of the Ottawa Hospital Research Institute (OHRI), as described previously (Arabzadeh et al., 2006; Turksen and Troy, 2002) . The presence of the transgene was confirmed by PCR using genomic DNA and specific primers. Photography of age-matched wild-type and Inv-Cldn6-C206 transgenic mice was performed using a Nikon Coolpix 950 digital camera (Nikon) and image processing was performed with Adobe Photoshop version 7.0 (Adobe Systems). All research was carried out in accordance with the principles and guidelines of the Canadian Council on Animal Care, and the policies of the OHRI Animal Care Committee.
dmm.biologists.orgRNA isolation and RT-PCR Skin samples dissected from the mid-dorsal region of transgenic and wild-type mice were frozen in liquid nitrogen, and then homogenized in Trizol (Invitrogen) reagent for total RNA isolation according to the instructions of the manufacturer. After DNase (Invitrogen) treatment, first-strand cDNA was synthesized using random hexamers (Applied Biosystems) and 1 g of RNA. PCR analysis was then performed, as decribed previously (Troy et al., 2005a) 
Skin permeability assays X-gal penetration assay
Freshly dissected Inv-Cldn6-C206 transgenic embryos (E15.5, E17.5 and E18.5; the embryonic age was estimated based on the appearance of the vaginal plug at E0.5) and euthanized neonates, along with their age-matched wild-type counterparts, were rinsed in PBS and immersed in X-Gal reaction mix at pH 4.5 [100 mM NaPO 4 , 1.3 mM MgCl 2 , 3 mM K 3 Fe(CN) 6 , 3 mM K 4 Fe(CN) 6 and 1 mg/ml X-Gal], as described previously (Hardman et al., 1998; Turksen and Troy, 2002; Turksen and Troy, 2003) . Following an overnight room temperature incubation, specimens were fixed with formalin and images were acquired using a Nikon Coolpix 950 digital camera followed by processing with Adobe Photoshop version 7.0.
Trans-epidermal water loss (TEWL) measurements
A dermal phase meter (DPM) (Nova Technology Corporation) was used to measure the dorsal and ventral impedance/TEWL of InvCldn6-C206 transgenic and wild-type mice, as described previously (Troy et al., 2005b; Turksen and Troy, 2002) , at various postnatal time points from birth to the emergence of coat hairs, at which time measurements are no longer feasible owing to improper contact between the meter probe and the skin. Higher DPM values measured over time translate to reduced barrier integrity, illustrated digitally by EDWINA (Nova Technology Corporation) and Excel (Microsoft) software programs.
Cornified envelope extracts
Purified cornified envelope extracts were prepared from CD1 and Inv-Cldn6-C206 transgenic mice by immersion of dorsal skin samples into hot extraction buffer (0.1M Tris-Hcl, pH 8.5, 2% SDS, 20 mM dithiothreitol, 5 mM EDTA), followed by a 15-minute incubation at 95°C and gentle centrifugation, as described previously (Hohl et al., 1991; Troy and Turksen, 2005; Turksen and Troy, 2002) .
Sample collection, histology and immunolocalization
Sample preparation
Freshly dissected skin samples (~1 cm 2 ) and whole embryos were collected from wild-type and Inv-Cldn6-C206 transgenic mice at various embryonic and postnatal time points (E15.5, E17.5, E18.5, newborn, and 2 days, 4 days, 6 days, 7 days, 8 days, 10 days, 12 days, 2 weeks, 3 weeks, 1 month and 3 months of age).
Paraffin sections and histology
Following an overnight fixation in Bouin's solution (75% saturated picric acid, 20% formaldehyde, 5% glacial acetic acid), skin samples were dehydrated by a graded series of ethanol washes (from 30% to 100%) and embedded in paraffin. Sections (5 m) were mounted onto Superfrost/Plus slides (Fisher Scientific), and were dewaxed using toluene and rehydrated in a reverse series of ethanol washes to water. Following antigen unmasking and washes in PBS, sections were either stained with hematoxylin and eosin (H&E), as described previously (Troy et al., 2005c) , or used for immunohistochemistry (see below).
Immunohistochemistry Non-specific antibody binding (10% goat serum, 0.8% BSA, 1% gelatin in PBS) was blocked, followed by incubation for 1 hour in antibodies that were diluted appropriately with incubation buffer (1% goat serum, 0.8% BSA, 1% gelatin in PBS) (Troy et al., 2005c) . Antibodies against the following antigens were evaluated: K15 (1:100; rabbit #UC55), K5 (1:100; rabbit #5054), K14 (1:100; rabbit #199), K1 (1:100; rabbit #UC81), K6 (1:200; BabCO), K17 (1:500; a gift from Dr Pierre Coulombe, Johns Hopkins University School of Medicine, Baltimore, MD), involucrin (1:100; BabCO), filaggrin (1:100; BabCO), loricrin (1:100; rabbit #UC84), Cldn1 (6:100; Zymed Laboratories), Cldn2 (1:200; Zymed Laboratories), Cldn3 (1:50; Zymed Laboratories), Cldn5 (1:100; Zymed Laboratories), Cldn6 (1:100; chicken #3677), Cldn11 (1:100; chicken #3680), Cldn12 (1:100; chicken #5186), Cldn18 (1:100; rabbit #A9953), NHE1 [3:100; Chemicon-AB3031 (incubation was overnight at 4°C)], phosphoCldn1 [1:100; a custom antibody generated from rabbit #2827 against the tail domain of the mouse phosphoCldn1 sequence (Ac-C-Ahx-PYPKP[pT]PSSGKDY-amide), 21st Century Biochemicals] and Erk1/2 (1:100; StressMarq Biosciences Inc.). After incubations in wash buffer (0.8% BSA, 1% gelatin in PBS), FITC-conjugated secondary antibodies against mouse, rabbit and chicken (1:50; Jackson ImmunoResearch) were diluted in incubation buffer and used for 1-hour incubations at room temperature. Following the final washes, skin samples were mounted with Mowiol 4-88 (Calbiochem), containing 2.5% 1,4 diazobicyclo-[2,2,2]-octane (DABCO; Sigma), for observation with a Zeiss Axioplan 2 fluorescence microscope equipped with an AxioCam camera and Axio Vision 2.05 software (Carl Zeiss). Digital photography was presented with Adobe Photoshop version 7.0.
Protein Isolation and Immunoblotting
Freshly dissected back skin samples (0.4 grams) were homogenized in SDS extraction buffer [62.5 mM Tris, pH 6.8, 25% glycerol, 2% SDS and 2% -mercaptoethanol, with pepstatin A and a complete mini protease inhibitor cocktail (Roche Diagnostics) tablet] followed by high-speed centrifugation. The supernatant containing the proteins was collected and assayed for protein concentration. Proteins were incubated at room temperature for 30 minutes in sample reducing buffer (62.5 mM Tris, pH 6.8, 6 M urea, 25% glycerol, 2% SDS, 0.1% Bromophenol Blue and 2% -mercaptoethanol), boiled for 5 minutes (samples were not boiled for analysis of NHE1), and centrifuged at high speed for 10 minutes before 5-50 g samples were separated on 7.5-12% SDS-PAGE gels, transferred to nitrocellulose and incubated in blocking buffer [5% skimmed milk in TBS/0.1% Tween-20 (TBS-T)] for 1 hour at room temperature. Appropriately diluted (5% skimmed milk in TBS-T) antibodies were used for overnight incubations at 4°C. The following antibodies were used: NHE1 (91 kDa, 1:1000; Chemicon), AQP1 (28 kDa, 1:1000; Alpha Diagnostic), Cldn1 (23 kDa, 1:1000; Zymed Laboratories) and GAPDH (36 kDa, 1:10,000; Abcam). After washing in TBS-T, blots were incubated for 1 hour at room temperature in HRP-conjugated secondary antibodies against rabbit or mouse (1:20,000; Amersham Biosciences), then diluted in 5% skimmed milk/TBS-T. Following washes in TBS-T, the Immobilon western blotting detection system (Millipore) was used for detection, and expression levels were normalized to a housekeeping control (GAPDH) and visualized on Kodak BioMax XAR film (Kodak). Films were digitally scanned and images were processed with Adobe Photoshop version 7.0.
RESEARCH ARTICLE TRANSLATIONAL IMPACT Clinical issue
An estimated 28% of the 4 million annual neonatal deaths are because of preterm birth. It is likely that many of these deaths result from an immature permeability barrier, leading to dehydration and infection with associated septic shock. The statistics published by the March of Dimes indicate a 36% increase in premature births in America in the last 25 years, and the cause is not understood. This is an alarming, and emotionally and ethically complex, situation that adds significant pressure to pediatric medicine. The absence of appropriate disease models in which to delineate the basis of barrier dysfunction and test new therapies limits progress in the field.
Results
Here, the authors characterize a mouse model that mimics a debilitating, nonfatal form of a dysfunctional epidermal permeability barrier, similar to that seen in human premature babies. The tight junction-associated proteins, claudins, play a crucial role in estabilishing the epidermal permeability barrier. One theory is that claudin-containing tight junctions act as command centers in which the claudin extracellular loops influence selective permeability, while their cytoplasmic tail domains send signals to other receptors to coordinate downstream effectors, such as the cytoskeleton. The transgenic mouse reported here contains a short claudin 6 tail truncation. This mutation results in a delayed and defective epidermal permeability barrier that, surprisingly, is repaired within 2-4 days after birth. The repair process was associated with remodeling of the claudin 1 expression domains that eliminated the defective differentiated epidermal cells and replaced them with apparently 'normal' and terminally differentiated epidermal cells. The trigger for repair appears to be exposure to air. The potential signaling pathways involved include the sphingosine-1-phosphate (S1P) pathway and preliminary observations implicate Erk1/2 downstream of the S1P-receptor 2. The relevance of this model for understanding human disease is confirmed by the authors' observations of similar features in specimens from premature babies, including dramatic delays in barrier formation and dysregulation of claudin expression, notably claudin 1.
Implications and future directions
Clinical outcomes for premature babies have been improved by using incubators that carefully control heat and humidity, but currently there are no therapeutic approaches for accelerating repair of the premature epidermal permeability barrier. The observation that activation of S1P and S1P-receptor 2 induce permeability repair processes suggests the therapeutic potential of selective receptor agonists. A few agonists have been described and this model is a viable model to test them. In summary, we think it is important to have made a model that mimics a repairable human epidermal permeability barrier, to have documented important cellular mechanisms of that repair, and to have begun delineation of the underlying molecular mechanisms, which are also pointing towards potential new therapies. doi:10.1242/dmm.005140
